Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus

Journal of Nuclear Medicine

Volumn 39, Issue 11, 1998, Pages 1835-1840

  Hattori, Naoya ^a   Tamaki, Nagara ^b   Kudoh, Takashi ^b   Masuda, Izuru ^b   Magata, Yasuhiro ^b   Kitano, Haruhiro ^b   Inubushi, Masayuki ^b   Tadamura, Eiji ^b   Nakao, Kazuwa ^b   Konishi, Junji ^b  

^a Nukleamedizinische Klinik   (Germany)

^b NONE

Author keywords

Diabetes; Myocardial oxidative metabolism

Indexed keywords

ACETIC ACID C 11; DOBUTAMINE;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; EXERCISE TEST; FEMALE; HEART MUSCLE METABOLISM; HEART WORK; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETATES; ADRENERGIC BETA-AGONISTS; ADULT; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DOBUTAMINE; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; OXYGEN CONSUMPTION; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031773323     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38:504-509.
2. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15: 109-116.
3. Orlander PR, Goff DC, Morrissey M, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 1994;43:897-902.
4. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90: 808-817.
5. vom Dahl J, Herman WH, Hicks RJ, et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation 1993;88:395-404.
6. Monti LD, Lucignani G, Landoni C, et al. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels. Diabetes 1995;44:537-542.
7. Ohtake T, Yokoyama I, Watanabe T, et al. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995;36:456-463.
8. Miller TR, Wallis JW, Landy BR, Gropler RJ, Sabharwal CL. Measurement of global and regional left ventricular function by cardiac PET. J Nucl Med 1994;35:999-1005.
9. 123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 1995;44:543-549.
10. Allman KC, Stevens MJ, Wieland DM, et al. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993;22:1425-1432.
11. Hattori N, Tamaki N, Hayashi T, et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 1996;37:1985-1990.
12. Kotzerke J, Hicks RJ, Wolfe E, et al. Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics. J Nucl Med 1990;31:1876-1883.
13. Miller TR, Wallis JW, Geltman EM, Bergmann SR. Three-dimensional functional images of myocardial oxygen consumption from positron tomography. J Nucl Med 1990;31:2064-2068.
14. Yano S, Tamaki N, Fujita T, et al. Motion correction in exercise first-pass radionuclide ventriculography without an external point source. J Nucl Med 1995;36:1941-1944.
15. Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989;30:187-193.
16. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med 1989;30:1489-1499.
17. Walsh MN, Geltman EM, Brown MA, et al. Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-11 acetate in patients with myocardial infarction. J Nucl Med 1989;30:1798-1808.
18. Tamaki N, Magata Y, Takahashi N, et al. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med 1993;20:231-237.
19. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990;31:1749-1756.
20. Hicks RJ, Herman WH, Kalff V, et al. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol 1991;18:101-111.
21. Rumberger JA, Feiring AJ, Lipton MJ, Higgins CB, Ell SR, Marcus ML. Use of ultrafast computed tomography to quantitate regional myocardial perfusion: a preliminary report. J Am Coll Cardiol 1987;9:59-69.
22. Pflugfelder PW, Sechtem UP, White RD, Higgins CB. Quantification of regional myocardial function by rapid cine MR imaging. AJR 1988;150:523-529.
23. Feiring AJ, Rumberger JA, Reiter SJ, et al. Sectional and segmental variability of left ventricular function: experimental and clinical studies using ultrafast computed tomography. J Am Coll Cardiol 1988;12:415-425.
24. Schwaiger M, Hicks R. Regional heterogeneity of cardiac substrate metabolism? J Nucl Med 1990;31:1757-1760.
25. Almira EC, Garcia AR, Boshell BR. Insulin binding and glucose transport activity in cardiomyocytes of a diabetic rat. Am J Physiol 1986;250:E402-E406.
26. Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997;336:1208-1215.
27. Schwaiger M, Hutchins G, Kalff V, Rosenspire K, Haka M, Mallette S. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991;87:1681-1690.
28. De Marco T, Dae M, Yuen-Green MS, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol 1995;25:927-931.
29. Hall JL, Stanley WC, Lopaschuk GD, et al. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol 1996;271:H2320-H2329.
30. Beanlands RS, Bach DS, Raylman R, et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993;22:1389-1398.
31. 2 consumption in normal human heart: effects of dobutamine. Am J Physiol 1993;265:H1884-H1892.
32. Monrad ES, Baim DS, Smith HS, Lanoue AS. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986;73:III168-III174.
33. Sundram P, Reddy HK, McElroy PA, Janicki JS, Weber KT. Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone. Am Heart J 1990;119:891-898.
34. Valette H, Deleuze P, Syrota A, et al. Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study. J Nucl Med 1995;36:140-146.
35. 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion. Circulation 1996;94:1834-1841.